Twelve Years Since the Demise of My Father
Remembering Charles F. Johnson: A Man Remembered for His Provision
In memory and honour of Charles F. Johnson, who passed away on July 13, 2013, we take a moment to reflect on his life. This article is dedicated to Charles F. Johnson (1947-2013).
As of the time of this article, memorial pages for Charles F. Johnson can be found on both Facebook and Twitter. These pages have been active for a significant period of time, serving as a platform for friends, family, and acquaintances to share memories, photos, and condolences.
Charles F. Johnson was a good provider, known for his care and support to those around him. His death was mourned on social media platforms, with many people expressing their sadness at his passing. For the speaker, losing a parent is always a difficult experience, and saying goodbye to Charles F. Johnson 12 years ago was no exception.
Charles F. Johnson's cause of death was not explicitly stated in the provided paragraph, but it is known that he was diagnosed with Leukemia. Treatment for Leukemia can be intense, and often includes chemotherapy, immunotherapy, bone marrow transplantation, and supportive care.
For a 12-year-old diagnosed with Leukemia, the 5-year survival rate for acute lymphoblastic leukemia (ALL), the most common childhood leukemia, is approximately 75-80%. These survival rates depend on various factors including subtype, risk group, and treatment response.
Advances in treatment have improved tolerance and outcomes for children and adolescents, making long-term survival and cure achievable for most. Immunotherapy, such as the drug blinatumomab, has recently been added to treatment protocols and has shown promise in improving survival rates for adolescents and young adults.
It is a reminder that while we remember and honour Charles F. Johnson, we also remember those who are currently battling Leukemia, and the progress that is being made in its treatment. Our thoughts and prayers are with them and their families during this difficult time.
Charles F. Johnson's battle with Leukemia, a medical-condition that affects the blood and bone marrow, was tragically lost, yet advancements in science, particularly in health-and-wellness research, have resulted in improved survival rates for those currently fighting the disease.
